Avior Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Avior Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-533	Closed	-$3.71K	–	1717
2024 Q4	$3.71K	Buy	533 +135	+34%	+$929	﹤0.01%	1968
2024 Q3	$2.26K	Hold	398	–	–	﹤0.01%	1959
2024 Q2	$2.87K	Buy	398 +374	+1,558%	+$3.27K	﹤0.01%	1874
2024 Q1	$225	Sell	24 -6	-20%	-$34	﹤0.01%	2827
2023 Q4	$109	Buy	30 +6	+25%	+$18	﹤0.01%	1486
2023 Q3	$75	Hold	24	–	–	﹤0.01%	1567
2023 Q2	$85	Hold	24	–	–	﹤0.01%	1530
2023 Q1	$76	Hold	24	–	–	﹤0.01%	1598
2022 Q4	$52	Hold	24	–	–	﹤0.01%	1257
2022 Q3	$0	Sell	24 -70	-74%	-$672	﹤0.01%	1238
2022 Q2	$0	Buy	+94	New	+$1.19K	﹤0.01%	1163

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avior Wealth Management's DFTX Position: Q1 2025 in Review

Avior Wealth Management sold out of Definium Therapeutics (DFTX) in Q1 2025, closing a stake of 533 shares — an estimated $3.71K sold.

Avior Wealth Management first reported a position in DFTX in Q2 2022 and held it in 11 quarters. The position peaked at $3.71K in Q4 2024. 190 funds tracked by Wall St. Rank hold DFTX as of Q1 2025.

Avior Wealth Management reported no remaining Definium Therapeutics position as of Q1 2025 after selling out during the quarter.
Avior Wealth Management sold 533 Definium Therapeutics shares in Q1 2025, an estimated $3.71K.
Avior Wealth Management first reported a position in Definium Therapeutics in Q2 2022 and held it in 11 quarters.
Avior Wealth Management's Definium Therapeutics position peaked at $3.71K in Q4 2024.
190 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2025.

Based on Avior Wealth Management's 13F filing for Q1 2025, filed 21 Apr 2025.